Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates

Brain and Development

Volumn 30, Issue 8, 2008, Pages 533-543

  Tsuda, Noriko ^a   Mizuno, Makoto ^a   Yamanaka, Takayuki ^a   Komurasaki, Toshi ^b   Yoshimoto, Makoto ^b   Nawa, Hiroyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Animal behavior; Body weight; Cytokine; EGF; Eyelid opening; Neurodevelopmental disorder; Sensorimotor gating; Tooth eruption

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; LIGAND; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEAR; LEARNING; LOCOMOTION; MOUSE; NEUROCHEMISTRY; NEWBORN; NONHUMAN; PHYSICAL DEVELOPMENT; PREPULSE INHIBITION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; STARTLE REFLEX; TOOTH DEVELOPMENT;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); EPIDERMAL GROWTH FACTOR; FEMALE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; RECEPTOR, EPIDERMAL GROWTH FACTOR; STARTLE REACTION; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 47149110256     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.01.006     Document Type: Article

References (44)

1. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., and Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251 (1991) 936-939
2. Komurasaki T., Toyoda H., Uchida D., and Morimoto S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene 15 (1997) 2841-2848
3. Strachan L., Murison J.G., Prestidge R.L., Sleeman M.A., Watson J.D., and Kumble K.D. Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J Biol Chem 276 (2001) 18265-18271
4. Saito T., Okada S., Ohshima K., Yamada E., Sato M., Uehara Y., et al. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology 145 (2004) 4232-4243
5. Gregory H., and Preston B.M. The primary structure of human urogastrone. Int J Pept Protein Res 9 (1977) 107-118
6. Okada M., Ohmura E., Kamiya Y., Murakami H., Onoda N., Iwashita M., et al. Transforming growth factor (TGF)-alpha in human milk. Life Sci 48 (1991) 1151-1156
7. Varner M.W., Dildy G.A., Hunter C., Dudley D.J., Clark S.L., and Mitchell M.D. Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies. J Soc Gynecol Investig 3 (1996) 17-19
8. Bastian S.E., Dunbar A.J., Priebe I.K., Owens P.C., and Goddard C. Measurement of betacellulin levels in bovine serum, colostrum and milk. J Endocrinol 168 (2001) 203-212
9. Lemos-González Y., Rodríguez-Berrocal F.J., Cordero O.J., Gómez C., and Páez de la Cadena M. Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma. Br J Cancer 96 (2007) 1569-1578
10. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 237 (1962) 1555-1562
11. Torring N., Jorgensen P.E., Sorensen B.S., and Nexo E. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res 20 (2000) 91-95
12. Oslislo A., Czuba Z., Slawska H., Kazmierczak W., and Krol W. Decreased human milk concentration of epidermal growth factor after preterm delivery of intrauterine growth-restricted newborns. J Pediatr Gastroenterol Nutr 44 (2007) 464-467
13. Futamura T., Kakita A., Tohmi M., Sotoyama H., Takahashi H., and Nawa H. Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol Psychiatry 8 (2003) 19-29
14. Nawa H., and Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56 (2006) 2-13
15. Seroogy K.B., Numan S., Gall C.M., Lee D.C., and Kornblum H.I. Expression of EGF receptor mRNA in rat nigrostriatal system. Neuroreport 6 (1994) 105-108
16. Campos L.S., Decker L., Taylor V., and Skarnes W. Notch, epidermal growth factor receptor, and beta1-integrin pathways are coordinated in neural stem cells. J Biol Chem 281 (2006) 5300-5309
17. Tohmi M., Tsuda N., Mizuno M., Takei N., Frankland P.W., and Nawa H. Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains. Behav Genet 35 (2005) 615-629
18. Mizuno M., Malta Jr. R.S., Nagano T., and Nawa H. Conditioned place preference and locomotor sensitization following repeated administration of cocaine or methamphetamine in rats treated with EGF during neonatal period. Ann NY Acad Sci 1025 (2004) 612-618
19. Braff D.L., and Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 47 (1990) 181-188
20. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156 (2001) 194-215
21. Kleshcheva R.P. The development of components of the blood-brain barrier in the neocortex of the white rat. Arkh Anat Gisto Embriol 95 (1988) 22-26
22. Namba H., Nagano T., Iwakura Y., Xiong H., Jourdi H., Takei N., et al. Transforming growth factor alpha attenuates the functional expression of AMPA receptors in cortical GABAergic neurons. Mol Cell Neurosci 31 (2006) 628-641
23. Nagano T., Namba H., Abe Y., Aoki H., Takei N., and Nawa H. In vivo administration of epidermal growth factor and its homologue attenuates developmental maturation of functional excitatory synapses in cortical GABAergic neurons. Eur J Neurosci 25 (2007) 380-390
24. Tohmi M., Tsuda N., Watanabe Y., Kakita A., and Nawa H. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin. Neurosci Res 50 (2004) 67-75
25. Watanabe Y., Hashimoto S., Kakita A., Takahashi H., Ko J., Mizuno M., et al. Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats. Neurosci Res 48 (2004) 345-353
26. Tsuda N., Tohmi M., Mizuno M., and Nawa H. Strain-dependent behavioral alterations induced by peripheral interleukin-1 challenge in neonatal mice. Behav Brain Res 166 (2006) 19-31
27. Hofmann G.E., and Abramowicz J.S. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet Gynecol Scand 69 (1990) 217-221
28. Tohmi M., Tsuda N., Zheng Y., Mizuno M., Sotoyama H., Shibuya M., et al. The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood-brain barrier of neonatal rats: a critical period for efficacy. Neuroscience 150 (2007) 234-250
29. Hilakivi-Clarke L.A., and Goldberg R. Effects of tryptophan and serotonin uptake inhibitors on behavior in male transgenic transforming growth factor alpha mice. Eur J Pharmacol 237 (1993) 101-108
30. Hilakivi-Clarke L., Durcan M., and Goldberg R. Effect of alcohol on elevated aggressive behavior in male transgenic TGF alpha mice. Neuroreport 4 (1993) 155-158
31. Koshibu K., and Levitt P. Transforming growth factor-alpha induces sex-specific neurochemical imbalance in the stress- and memory-associated brain structures. Neuropharmacology 50 (2006) 807-813
32. Koshibu K., Ahrens E.T., and Levitt P. Postpubertal sex differentiation of forebrain structures and functions depend on transforming growth factor-alpha. J Neurosci 25 (2005) 3870-3880
33. O'Callaghan E., Sham P., Takei N., Glover G., and Murray R.M. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 337 (1991) 1248-1250
34. O'Callaghan E., Gibson T., Colohan H.A., Buckley P., Walshe D.G., Larkin C., et al. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. Br Med J 305 (1992) 1256-1259
35. Tanaka N., Sasahara M., Ohno M., Higashiyama S., Hayase Y., and Shimada M. Heparin-binding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury. Brain Res 827 (1999) 130-138
36. Opanashuk L.A., Mark R.J., Porter J., Damm D., Mattson M.P., and Seroogy K.B. Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action. J Neurosci 19 (1999) 133-146
37. Kawahara N., Mishima K., Higashiyama S., Taniguchi N., Tamura A., and Kirino T. The gene for heparin-binding epidermal growth factor-like growth factor is stress-inducible: its role in cerebral ischemia. J Cereb Blood Flow Metab 19 (1999) 307-320
38. Isono M., Goda M., Kobayashi H., and Wu J.L. TGF-alpha overexpression induces astnding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury. Neurol Res 25 (2003) 546-550
39. Romeo R.D., Fossella J.A., Bateup H.S., Sisti H.M., Brake W.G., and McEwen B.S. Maternal separation suppresses TGF alpha mRNA expression in the prefrontal cortex of male and female neonatal C57BL/6 mice. Dev Brain Res 152 (2004) 73-77
40. Hadjiconstantinou M., Fitkin J.G., Dalia A., and Neff N.H. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-treated mouse. J Neurochem 57 (1991) 479-482
41. Hanke M., Farkas L.M., Jakob M., Ries R., Pohl J., and Sullivan A.M. Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo. Neuroscience 124 (2004) 757-766
42. Iwakura Y., Piao Y.S., Mizuno M., Takei N., Kakita A., Takahashi H., et al. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. J Neurochem 93 (2005) 974-983
43. Yokomaku D., Jourdi H., Kakita A., Nagano T., Takahashi H., Takei N., et al. ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins, GRIP1 and SAP97, in developing neocortex. Neuroscience 136 (2005) 1037-1047
44. Li B., Woo R.S., Mei L., and Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54 (2007) 583-597